Atlas Trials

Covid-19 Vaccine Response in Immunocompromised Haematology Patients

Clinical trial NCT04805216 · COMPLETED

Trial details

NCT number
NCT04805216
Sponsor
University Hospitals of North Midlands NHS Trust
Status
COMPLETED
Study type
OBSERVATIONAL
Covid19Haematological DisordersImmune Suppression
Start date
2021-03-15
Primary completion
2022-04-30
Enrollment
75

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.